Reliance Life Sciences Pvt Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is ERLOTINIB HYDROCHLORIDE, with a corresponding US DMF Number 25978.
Remarkably, this DMF maintains an Active status since its submission on May 16, 2012, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of March 05, 2021, and payment made on January 20, 2021, indicating their dedication to facilitating drug approvals, Categorized as Type II